Medicine
Raloxifene 60 mg tablet
Raloxifene 60 mg tablet is a generic prescription medicine for oral use, made by 16 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 20° to 25°C (68° to 77°F). The USP…
Key facts
- Active ingredient (INN)
- Raloxifene
- Brand
- Sold under the generic name
- Strength
- 60 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 3 blister pack, 2000 tablets and 50 more
- Manufacturers
- Aurobindo PharmaIndiaCadila PharmaceuticalsIndiaCiplaIndiaDr. Reddy's LaboratoriesIndiaAmneal PharmaceuticalsBryant Ranch PrepackExelan PharmaceuticalsModavar PharmaceuticalsScieGen PharmaceuticalsTeva Pharmaceuticals16 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 20° to 25°C (68° to 77°F). The USP defines controlled room temperature as a temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F), that results in a mean kinetic temperature calculated to be not more than 25°C, and that allows for excursions between 15° and 30°C (59° and 86°F) that…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03XC01 Raloxifene
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 March 2014
- Identifiers
- RxCUI 1490065DailyMed set ID 6fd63a06-5bc5-4c50-9b85-b09c89100b80, 53a2db10-4af8-4032-b598-b7c7a0969801, 3798c70b-a4b0-4811-9788-e4c9cff47ebe +18NDC 71610-053, 71610-524, 65162-057 +18Application ANDA206384, ANDA090842, ANDA208206 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 16 labelers. The register lists 53 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65862-709-01 | Aurobindo PharmaIndia | 28 August 2015 |
| 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-709-03 | Aurobindo PharmaIndia | 28 August 2015 |
| 2000 tablet, film coated in 1 bottle | 65862-709-22 | Aurobindo PharmaIndia | 28 August 2015 |
| 30 tablet, film coated in 1 bottle | 65862-709-30 | Aurobindo PharmaIndia | 28 August 2015 |
| 1000 tablet, film coated in 1 bottle | 65862-709-99 | Aurobindo PharmaIndia | 28 August 2015 |
| 30 tablet, coated in 1 bottle | 71209-082-01 | Cadila PharmaceuticalsIndia | 30 December 2017 |
| 100 tablet, coated in 1 bottle | 71209-082-05 | Cadila PharmaceuticalsIndia | 30 December 2017 |
| 1000 tablet, coated in 1 bottle | 71209-082-11 | Cadila PharmaceuticalsIndia | 13 December 2021 |
| 2000 tablet, coated in 1 bottle | 71209-082-13 | Cadila PharmaceuticalsIndia | 30 December 2017 |
| 30 tablet in 1 bottle | 69097-825-02 | CiplaIndia | 29 June 2016 |
| 100 tablet in 1 bottle | 69097-825-07 | CiplaIndia | 29 June 2016 |
| 1000 tablet in 1 bottle | 69097-825-15 | CiplaIndia | 29 June 2016 |
| 100 tablet, film coated in 1 bottle | 43598-505-01 | Dr. Reddy's LaboratoriesIndia | 12 October 2016 |
| 1000 tablet, film coated in 1 bottle | 43598-505-10 | Dr. Reddy's LaboratoriesIndia | 12 October 2016 |
| 30 tablet, film coated in 1 bottle | 43598-505-30 | Dr. Reddy's LaboratoriesIndia | 12 October 2016 |
| 30 tablet, film coated in 1 bottle | 65162-057-03 | Amneal Pharmaceuticals | 20 January 2016 |
| 90 tablet, film coated in 1 bottle | 65162-057-09 | Amneal Pharmaceuticals | 20 January 2016 |
| 100 tablet, film coated in 1 bottle | 65162-057-10 | Amneal Pharmaceuticals | 20 January 2016 |
| 1000 tablet, film coated in 1 bottle | 65162-057-11 | Amneal Pharmaceuticals | 20 January 2016 |
| 2000 tablet, film coated in 1 bottle | 65162-057-33 | Amneal Pharmaceuticals | 20 January 2016 |
| 500 tablet, film coated in 1 bottle | 65162-057-50 | Amneal Pharmaceuticals | 20 January 2016 |
| 100 tablet, film coated in 1 bottle | 76282-256-01 | Exelan Pharmaceuticals | 12 November 2014 |
| 500 tablet, film coated in 1 bottle | 76282-256-05 | Exelan Pharmaceuticals | 12 November 2014 |
| 1000 tablet, film coated in 1 bottle | 76282-256-10 | Exelan Pharmaceuticals | 15 April 2015 |
| 30 tablet, film coated in 1 bottle | 76282-256-30 | Exelan Pharmaceuticals | 12 November 2014 |
| 90 tablet, film coated in 1 bottle | 76282-256-90 | Exelan Pharmaceuticals | 15 April 2015 |
| 100 tablet, coated in 1 bottle | 72241-010-05 | Modavar Pharmaceuticals | 30 December 2017 |
| 1000 tablet, coated in 1 bottle | 72241-010-11 | Modavar Pharmaceuticals | 30 December 2017 |
| 2000 tablet, coated in 1 bottle | 72241-010-13 | Modavar Pharmaceuticals | 30 December 2017 |
| 30 tablet, coated in 1 bottle | 72241-010-22 | Modavar Pharmaceuticals | 30 December 2017 |
| 2000 tablet, film coated in 1 bottle | 50228-306-20 | ScieGen Pharmaceuticals | 12 October 2016 |
| 30 tablet, film coated in 1 bottle | 50228-306-30 | ScieGen Pharmaceuticals | 12 October 2016 |
| 100 tablet, film coated in 1 bottle | 0093-7290-01 | Teva Pharmaceuticals | 28 March 2014 |
| 30 tablet, film coated in 1 bottle | 0093-7290-56 | Teva Pharmaceuticals | 28 March 2014 |
| 60 tablet, film coated in 1 bottle | 71335-1460-1 | Bryant Ranch Prepack | 3 January 2020 |
| 30 tablet, film coated in 1 bottle | 71335-1460-2 | Bryant Ranch Prepack | 28 December 2021 |
| 60 tablet, film coated in 1 bottle | 71335-1715-1 | Bryant Ranch Prepack | 2 October 2020 |
| 30 tablet, film coated in 1 bottle | 71335-1715-2 | Bryant Ranch Prepack | 29 December 2021 |
| 60 tablet, film coated in 1 bottle | 71335-2059-1 | Bryant Ranch Prepack | 3 March 2022 |
| 30 tablet, film coated in 1 bottle | 71335-2059-2 | Bryant Ranch Prepack | 27 February 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Raloxifene 60 mg tablet.
Clinical summary
Raloxifene is an estrogen agonist/antagonist indicated for treatment and prevention of osteoporosis in postmenopausal women, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Raloxifene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RaloxifeneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Evista prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
- Evista: European public assessment report (EPAR) · European Medicines Agency
- Raloxifene Teva: European public assessment report (EPAR) · European Medicines Agency
Need Raloxifene 60 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.